ISG15 and cancer: The covalent modification of ISG15 also negatively regulates the ubiquitin-protease system to generate more reactive oxygen species (ROS); high levels of ROS enhance the enzymatic activity of p38/MAPK and the expression of inflammation-related cytokines in macrophages, which accelerates inflammation and cancer transformation [74].